736 related articles for article (PubMed ID: 19667545)
1. Optimal antibiotic dosing. The pharmacokinetic-pharmacodynamic interface.
Reed MD
Postgrad Med; 2000 Dec; 108(7 Suppl Contemporaty):17-24. PubMed ID: 19667545
[TBL] [Abstract][Full Text] [Related]
2. Application of pharmacokinetics and pharmacodynamics to antimicrobial therapy of respiratory tract infections.
Andes D; Anon J; Jacobs MR; Craig WA
Clin Lab Med; 2004 Jun; 24(2):477-502. PubMed ID: 15177850
[TBL] [Abstract][Full Text] [Related]
3. Bacterial resistance in the new millennium. Its impact on antibiotic selection for respiratory tract infections.
Appelbaum PC
Postgrad Med; 2000 Dec; 108(7 Suppl Contemporaty):5-16. PubMed ID: 19667544
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine.
McKellar QA; Sanchez Bruni SF; Jones DG
J Vet Pharmacol Ther; 2004 Dec; 27(6):503-14. PubMed ID: 15601444
[TBL] [Abstract][Full Text] [Related]
5. How can we predict bacterial eradication?
Jacobs MR
Int J Infect Dis; 2003 Mar; 7 Suppl 1():S13-20. PubMed ID: 12839703
[TBL] [Abstract][Full Text] [Related]
6. Selecting antibiotics based on pharmacokinetic and pharmacodynamic principles.
Klutman NE
Pharm Pract Manag Q; 1996 Jul; 16(2):9-12. PubMed ID: 10161616
[TBL] [Abstract][Full Text] [Related]
7. Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters.
Jacobs MR
Clin Microbiol Infect; 2001 Nov; 7(11):589-96. PubMed ID: 11737083
[TBL] [Abstract][Full Text] [Related]
8. [Therapeutic antimicrobial agents for postoperative infections: appropriate use of antibiotics from the viewpoint of pharmacokinetic/pharmacodynamic theory].
Takesue Y; Nakajima K; Wada Y; Ichiki K; Yanagi H; Ikeuchi H
Nihon Geka Gakkai Zasshi; 2006 Sep; 107(5):224-9. PubMed ID: 17017418
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic-pharmacodynamic modelling of antibacterial activity of cefpodoxime and cefixime in in vitro kinetic models.
Liu P; Rand KH; Obermann B; Derendorf H
Int J Antimicrob Agents; 2005 Feb; 25(2):120-9. PubMed ID: 15664481
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamics: relation to antimicrobial resistance.
Rybak MJ
Am J Infect Control; 2006 Jun; 34(5 Suppl 1):S38-45; discussion S64-73. PubMed ID: 16813981
[TBL] [Abstract][Full Text] [Related]
11. [Blood and respiratory diffusion of antibiotics. A critical analysis of predictive parameters for clinical effectiveness].
Fantin B
Med Mal Infect; 2006; 36(11-12):599-613. PubMed ID: 16837154
[TBL] [Abstract][Full Text] [Related]
12. Choosing an antibiotic on the basis of pharmacodynamics.
Craig WA
Ear Nose Throat J; 1998 Jun; 77(6 Suppl):7-11; discussion 11-2. PubMed ID: 9674328
[TBL] [Abstract][Full Text] [Related]
13. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ
Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
[TBL] [Abstract][Full Text] [Related]
14. Correlation of in vitro activity and pharmacokinetic parameters with effect in vivo for antibiotics. Observations from experimental pneumococcus infection.
Frimodt-Møller N
Dan Med Bull; 1988 Oct; 35(5):422-37. PubMed ID: 3066588
[TBL] [Abstract][Full Text] [Related]
15. Activity of garenoxacin, an investigational des-F(6)-quinolone, tested against pathogens from community-acquired respiratory tract infections, including those with elevated or resistant-level fluoroquinolone MIC values.
Jones RN; Fritsche TR; Sader HS; Stilwell MG
Diagn Microbiol Infect Dis; 2007 May; 58(1):9-17. PubMed ID: 17408903
[TBL] [Abstract][Full Text] [Related]
16. Rational dosing of antimicrobial agents: pharmacokinetic and pharmacodynamic strategies.
Owens RC; Shorr AF
Am J Health Syst Pharm; 2009 Jun; 66(12 Suppl 4):S23-30. PubMed ID: 19502225
[TBL] [Abstract][Full Text] [Related]
17. [Clinical implications of antibiotic pharmacokinetic-pharmacodynamic parameters].
Cohen R
Arch Pediatr; 2008 Oct; 15 Suppl 2():S53-8. PubMed ID: 19000855
[TBL] [Abstract][Full Text] [Related]
18. Relevance of pharmacokinetics and pharmacodynamics in the selection of antibiotics for respiratory tract infections.
Drusano GL; Craig WA
J Chemother; 1997 May; 9 Suppl 3():38-44. PubMed ID: 9248979
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and pharmacodynamics of oral beta-lactam antibiotics as a two-dimensional approach to their efficacy.
Auckenthaler R
J Antimicrob Chemother; 2002 Jul; 50 Suppl():13-7. PubMed ID: 12077155
[TBL] [Abstract][Full Text] [Related]
20. Does the dose matter?
Craig WA
Clin Infect Dis; 2001 Sep; 33 Suppl 3():S233-7. PubMed ID: 11524724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
